Protocol for preparing murine fecal microbiota transplant and fecal microbiota metabolites for in vivo and in vitro use
- PMID: 41317323
- PMCID: PMC12702311
- DOI: 10.1016/j.xpro.2025.104240
Protocol for preparing murine fecal microbiota transplant and fecal microbiota metabolites for in vivo and in vitro use
Abstract
Accumulating evidence demonstrates that microbiota-derived metabolites can modulate host immune responses and influence complex pathologies. Despite their therapeutic potential, the isolation of fecal microbial metabolites and their scalable ex vivo production remain challenging. Here, we present a protocol for preparing murine fecal microbiota transplant (FMT) and fecal microbiota metabolites for in vivo and in vitro use. We describe steps for collecting and preparing donor feces, isolating fecal microbial metabolites, and producing fecal microbial metabolites ex vivo with a broth expansion culture. For complete details on the use and execution of this protocol, please refer to Phelps et al.1.
Keywords: metabolism; metabolomics; microbiology; model organisms; molecular/chemical probes.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures
References
-
- Phelps C.M., Willis N.B., Duan T., Lee A.H., Zhang Y., Rodriguez J D.M., Pandey S.P., Laughlin C.R., Rosen A.B.I., McPherson A.C., et al. Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy. Cell. 2025;188:5680–5700.e28. doi: 10.1016/j.cell.2025.06.018. - DOI - PMC - PubMed
-
- Bender M.J., McPherson A.C., Phelps C.M., Pandey S.P., Laughlin C.R., Shapira J.H., Medina Sanchez L., Rana M., Richie T.G., Mims T.S., et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023;186:1846–1862.e26. doi: 10.1016/j.cell.2023.03.011. - DOI - PMC - PubMed
-
- Pandey S.P., Bender M.J., McPherson A.C., Phelps C.M., Sanchez L.M., Rana M., Hedden L., Sangani K.A., Chen L., Shapira J.H., et al. Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis. Cell Host Microbe. 2022;30:1003–1019.e10. doi: 10.1016/j.chom.2022.05.006. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
